STACY KAREM: Open Payments
NPI 1083346860 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 34 payments from 13 companies in 2025. Trend: 2023 $544 · 2024 $464 · 2025 $1,277
Food & beverage: $1,242Education: $35
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $374 |
| Ferring Pharmaceuticals Inc. | 3 | $246 |
| Olympus America Inc. | 10 | $214 |
| Antares Pharma, Inc. | 5 | $118 |
| Sumitomo Pharma America, Inc. | 4 | $110 |
| ACCORD HEALTHCARE, INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| ABBVIE INC. | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Endo USA, Inc. | 1 | $23 |
Products named: ADSTILADRIN, INTERSTIM, iTIND System, ALTAVIVA, XYOSTED, GEMTESA, Camcevi, IMFINZI.
Industry payments across IN — which companies pay providers there.
